The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Opioid Induced Constipation Treatment-Global Market Insights and Sales Trends 2024
Synopsis
Although opioids are very effective for treating and managing pain, their use frequently results in opioid-induced constipation (OIC). Treatment options for OIC may be as simple as changing diet or as complicated as requiring several medicines and laxatives.
The global Opioid Induced Constipation Treatment market size is expected to reach US$ 3490.4 million by 2029, growing at a CAGR of 4.6% from 2023 to 2029. The market is mainly driven by the significant applications of Opioid Induced Constipation Treatment in various end use industries. The expanding demands from the Drug Store and Hospital Pharmacies, are propelling Opioid Induced Constipation Treatment market. Oral, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Parenteral (Subcutaneous Injection) segment is estimated at % CAGR for the next seven-year period.
Global Opioid-Induced Constipation key players include Sanofi, Bayer, Purdue Pharm, etc. Global top three manufacturers hold a share over 45%.
North America is the largest market, with a share about 55%, followed by Europe, and Asia-Pacific, both have a share about 35 percent.
In terms of product, Lubiprostone is the largest segment, with a share about 5%. And in terms of application, the largest application is Pharmacy, followed by Hospital, etc.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Opioid Induced Constipation Treatment, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Opioid Induced Constipation Treatment market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Opioid Induced Constipation Treatment market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Opioid Induced Constipation Treatment sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Opioid Induced Constipation Treatment covered in this report include GlaxoSmithKline, AstraZeneca, Pfizer, S.L.A. Pharma, AIKO Biotechnology, Cubist Pharmaceuticals, Salix Pharmaceuticals and Takeda Pharmaceutical, etc.
The global Opioid Induced Constipation Treatment market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
GlaxoSmithKline
AstraZeneca
Pfizer
S.L.A. Pharma
AIKO Biotechnology
Cubist Pharmaceuticals
Salix Pharmaceuticals
Takeda Pharmaceutical
Global Opioid Induced Constipation Treatment market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Opioid Induced Constipation Treatment market, Segment by Type:
Oral
Parenteral (Subcutaneous Injection)
Global Opioid Induced Constipation Treatment market, by Application
Drug Store
Hospital Pharmacies
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Opioid Induced Constipation Treatment companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Although opioids are very effective for treating and managing pain, their use frequently results in opioid-induced constipation (OIC). Treatment options for OIC may be as simple as changing diet or as complicated as requiring several medicines and laxatives.
The global Opioid Induced Constipation Treatment market size is expected to reach US$ 3490.4 million by 2029, growing at a CAGR of 4.6% from 2023 to 2029. The market is mainly driven by the significant applications of Opioid Induced Constipation Treatment in various end use industries. The expanding demands from the Drug Store and Hospital Pharmacies, are propelling Opioid Induced Constipation Treatment market. Oral, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Parenteral (Subcutaneous Injection) segment is estimated at % CAGR for the next seven-year period.
Global Opioid-Induced Constipation key players include Sanofi, Bayer, Purdue Pharm, etc. Global top three manufacturers hold a share over 45%.
North America is the largest market, with a share about 55%, followed by Europe, and Asia-Pacific, both have a share about 35 percent.
In terms of product, Lubiprostone is the largest segment, with a share about 5%. And in terms of application, the largest application is Pharmacy, followed by Hospital, etc.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Opioid Induced Constipation Treatment, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Opioid Induced Constipation Treatment market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Opioid Induced Constipation Treatment market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Opioid Induced Constipation Treatment sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Opioid Induced Constipation Treatment covered in this report include GlaxoSmithKline, AstraZeneca, Pfizer, S.L.A. Pharma, AIKO Biotechnology, Cubist Pharmaceuticals, Salix Pharmaceuticals and Takeda Pharmaceutical, etc.
The global Opioid Induced Constipation Treatment market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
GlaxoSmithKline
AstraZeneca
Pfizer
S.L.A. Pharma
AIKO Biotechnology
Cubist Pharmaceuticals
Salix Pharmaceuticals
Takeda Pharmaceutical
Global Opioid Induced Constipation Treatment market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Opioid Induced Constipation Treatment market, Segment by Type:
Oral
Parenteral (Subcutaneous Injection)
Global Opioid Induced Constipation Treatment market, by Application
Drug Store
Hospital Pharmacies
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Opioid Induced Constipation Treatment companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Opioid Induced Constipation Treatment
1.1 Opioid Induced Constipation Treatment Market Overview
1.1.1 Opioid Induced Constipation Treatment Product Scope
1.1.2 Opioid Induced Constipation Treatment Market Status and Outlook
1.2 Global Opioid Induced Constipation Treatment Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Opioid Induced Constipation Treatment Market Size by Region (2018-2029)
1.4 Global Opioid Induced Constipation Treatment Historic Market Size by Region (2018-2023)
1.5 Global Opioid Induced Constipation Treatment Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Opioid Induced Constipation Treatment Market Size (2018-2029)
1.6.1 North America Opioid Induced Constipation Treatment Market Size (2018-2029)
1.6.2 Europe Opioid Induced Constipation Treatment Market Size (2018-2029)
1.6.3 Asia-Pacific Opioid Induced Constipation Treatment Market Size (2018-2029)
1.6.4 Latin America Opioid Induced Constipation Treatment Market Size (2018-2029)
1.6.5 Middle East & Africa Opioid Induced Constipation Treatment Market Size (2018-2029)
2 Opioid Induced Constipation Treatment Market by Type
2.1 Introduction
2.1.1 Oral
2.1.2 Parenteral (Subcutaneous Injection)
2.2 Global Opioid Induced Constipation Treatment Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Opioid Induced Constipation Treatment Historic Market Size by Type (2018-2023)
2.2.2 Global Opioid Induced Constipation Treatment Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Opioid Induced Constipation Treatment Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Opioid Induced Constipation Treatment Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Opioid Induced Constipation Treatment Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Opioid Induced Constipation Treatment Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Opioid Induced Constipation Treatment Revenue Breakdown by Type (2018-2029)
3 Opioid Induced Constipation Treatment Market Overview by Application
3.1 Introduction
3.1.1 Drug Store
3.1.2 Hospital Pharmacies
3.2 Global Opioid Induced Constipation Treatment Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Opioid Induced Constipation Treatment Historic Market Size by Application (2018-2023)
3.2.2 Global Opioid Induced Constipation Treatment Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Opioid Induced Constipation Treatment Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Opioid Induced Constipation Treatment Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Opioid Induced Constipation Treatment Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Opioid Induced Constipation Treatment Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Opioid Induced Constipation Treatment Revenue Breakdown by Application (2018-2029)
4 Opioid Induced Constipation Treatment Competition Analysis by Players
4.1 Global Opioid Induced Constipation Treatment Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Opioid Induced Constipation Treatment as of 2022)
4.3 Date of Key Players Enter into Opioid Induced Constipation Treatment Market
4.4 Global Top Players Opioid Induced Constipation Treatment Headquarters and Area Served
4.5 Key Players Opioid Induced Constipation Treatment Product Solution and Service
4.6 Competitive Status
4.6.1 Opioid Induced Constipation Treatment Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 GlaxoSmithKline
5.1.1 GlaxoSmithKline Profile
5.1.2 GlaxoSmithKline Main Business
5.1.3 GlaxoSmithKline Opioid Induced Constipation Treatment Products, Services and Solutions
5.1.4 GlaxoSmithKline Opioid Induced Constipation Treatment Revenue (US$ Million) & (2018-2023)
5.1.5 GlaxoSmithKline Recent Developments
5.2 AstraZeneca
5.2.1 AstraZeneca Profile
5.2.2 AstraZeneca Main Business
5.2.3 AstraZeneca Opioid Induced Constipation Treatment Products, Services and Solutions
5.2.4 AstraZeneca Opioid Induced Constipation Treatment Revenue (US$ Million) & (2018-2023)
5.2.5 AstraZeneca Recent Developments
5.3 Pfizer
5.3.1 Pfizer Profile
5.3.2 Pfizer Main Business
5.3.3 Pfizer Opioid Induced Constipation Treatment Products, Services and Solutions
5.3.4 Pfizer Opioid Induced Constipation Treatment Revenue (US$ Million) & (2018-2023)
5.3.5 S.L.A. Pharma Recent Developments
5.4 S.L.A. Pharma
5.4.1 S.L.A. Pharma Profile
5.4.2 S.L.A. Pharma Main Business
5.4.3 S.L.A. Pharma Opioid Induced Constipation Treatment Products, Services and Solutions
5.4.4 S.L.A. Pharma Opioid Induced Constipation Treatment Revenue (US$ Million) & (2018-2023)
5.4.5 S.L.A. Pharma Recent Developments
5.5 AIKO Biotechnology
5.5.1 AIKO Biotechnology Profile
5.5.2 AIKO Biotechnology Main Business
5.5.3 AIKO Biotechnology Opioid Induced Constipation Treatment Products, Services and Solutions
5.5.4 AIKO Biotechnology Opioid Induced Constipation Treatment Revenue (US$ Million) & (2018-2023)
5.5.5 AIKO Biotechnology Recent Developments
5.6 Cubist Pharmaceuticals
5.6.1 Cubist Pharmaceuticals Profile
5.6.2 Cubist Pharmaceuticals Main Business
5.6.3 Cubist Pharmaceuticals Opioid Induced Constipation Treatment Products, Services and Solutions
5.6.4 Cubist Pharmaceuticals Opioid Induced Constipation Treatment Revenue (US$ Million) & (2018-2023)
5.6.5 Cubist Pharmaceuticals Recent Developments
5.7 Salix Pharmaceuticals
5.7.1 Salix Pharmaceuticals Profile
5.7.2 Salix Pharmaceuticals Main Business
5.7.3 Salix Pharmaceuticals Opioid Induced Constipation Treatment Products, Services and Solutions
5.7.4 Salix Pharmaceuticals Opioid Induced Constipation Treatment Revenue (US$ Million) & (2018-2023)
5.7.5 Salix Pharmaceuticals Recent Developments
5.8 Takeda Pharmaceutical
5.8.1 Takeda Pharmaceutical Profile
5.8.2 Takeda Pharmaceutical Main Business
5.8.3 Takeda Pharmaceutical Opioid Induced Constipation Treatment Products, Services and Solutions
5.8.4 Takeda Pharmaceutical Opioid Induced Constipation Treatment Revenue (US$ Million) & (2018-2023)
5.8.5 Takeda Pharmaceutical Recent Developments
6 North America
6.1 North America Opioid Induced Constipation Treatment Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Opioid Induced Constipation Treatment Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Opioid Induced Constipation Treatment Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Opioid Induced Constipation Treatment Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Opioid Induced Constipation Treatment Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Opioid Induced Constipation Treatment Market Dynamics
11.1 Opioid Induced Constipation Treatment Industry Trends
11.2 Opioid Induced Constipation Treatment Market Drivers
11.3 Opioid Induced Constipation Treatment Market Challenges
11.4 Opioid Induced Constipation Treatment Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
